Role of mesenchymal stem cells in the blood stem cell niche
Role of mesenchymal stem cells in the blood stem cell niche
批准号:
7928911
负责人:
Paul S Frenette
金额:
$41.5万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-06 至 2013-07-31
关键词:
AblationAdipocytesAdultAortaBehaviorBloodBlood VesselsBone MarrowBone Marrow CellsCD34 geneCell MaintenanceCell ProliferationCellsCeramicsCharacteristicsChondrocytesCollaborationsDataDevelopmentDiseaseDoxycyclineEmbryoFetal LiverFiberFluorescenceGene ExpressionGenesGonadal structureHematopoiesisHematopoieticHematopoietic stem cellsHumanImageImplantIn VitroIntermediate Filament ProteinsLabelLaboratoriesLocationMapsMarrowMesenchymalMesenchymal Stem CellsMesonephric structureMethodsModelingMusMyelofibrosisNuclearOklahomaOsteoblastsProteinsRegulatory ElementRoleSickle Cell AnemiaSignal TransductionSiteSorting - Cell MovementSpleenStagingStaining methodStainsStem cellsSympathetic Nervous SystemTechniquesTissue-Specific Gene ExpressionToxinTransgenic Micecell typein vivomouse modelnerve supplynestin proteinnovelpostnatalprogenitorpromoterpublic health relevanceself-renewalspatial relationshipstem cell nichetissue culturetrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): HSCs inhabit specific niches that regulate their commitment, survival, proliferation and differentiation. However the cellular constituents of the HSC niche remain unclear. Several lines of evidence have suggested a role for osteoblasts in providing a specific site where HSCs are maintained in a quiescent state. Other data have suggested that HSCs are predominantly localized near sinusoidal vessels in the bone marrow and spleen. We have recently found that the trafficking, both enforced and homeostatic, is regulated by signals from the sympathetic nervous system (SNS). Searching for the cellular stromal target of the SNS, we have found using a mouse expressing the green fluorescence protein (GFP) under the Nestin gene promoter, that GFP expressing cells formed the HSC niche. Our preliminary data suggest that the vast majority of CD150+CD48- HSCs and SNS-fibers are localized near Nestin+ cells, and that these cells express high levels of key genes involved in stem cell maintenance. Upon culturing, sorted Nestin+ cells rapidly differentiate into mesenchymal lineages. Moreover, we show using novel culture methods that sorted Nestin+ cells can self-renew in vitro or in vivo when grown as spheres (termed "mesenspheres") in non-adherent dishes or attached to ceramic cubes implanted subcutaneously. We thus hypothesize that Nestin+ cells are bona fide mesenchymal stem cells which are tightly regulated by the SNS, and which form the HSC niche in both medullary and extra-medullary sites. We will explore this hypothesis with our collaborators in three Specific Aims. In Specific Aim I, we will evaluate the spatial location and relationships of HSCs with Nestin+ cells in the aorta-gonad-mesonephros (AGM) region and the fetal liver. We will assess the impact of Nestin+ cell depletion on hematopoiesis at these stages. We will study a subset of Nestin+ niche cells expressing the early osteoblast gene Osterix using promoter-driven doxycycline-induced expression. We will evaluate differential gene expression in sorted fetal liver and bone marrow-derived Nestin+ cells to identify novel niche regulators of HSC proliferation. In Specific Aim II, we will characterize the spatial localization and mobilization behavior of quiescent HSCs within the bone marrow using novel imaging models using mCherry red expressing Nestin+ cells and GFP label-retaining HSCs. In Specific Aim III, we will assess the number and function of Nestin+ niche cells in pathological models of myelofibrosis (bone marrow attrition) and sickle cell disease (bone marrow expansion). The analyses proposed in these pathologically relevant models will lay the groundwork for studies to define core universal niche genes whose function extends beyond anatomical or developmental confines.
PUBLIC HEALTH RELEVANCE: The spatial localization and cellular constituents forming the hematopoietic stem cell (HSC) niche are unclear, with studies suggesting that HSC localizes either near osteoblasts or the vasculature. Preliminary studies supporting this proposal suggest that bona fide mesenchymal stem cells, peri-vascular and isolatable by Nestin expression, form a unique HSC niche in the bone marrow. This proposal explores the function of this candidate niche cell during the normal development and pathological states of bone marrow attrition and expansion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating neural circuitry of the bone marrow
-
批准号:9768488
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2017
-
负责人:Paul S Frenette
-
依托单位:
In vivo function of macrophage in healthy and diseased erythropoiesis
-
批准号:8417074
-
项目类别:
-
资助金额:$43.46万
-
财政年份:2012
-
负责人:Paul S Frenette
-
依托单位:
In vivo function of macrophage in healthy and diseased erythropoiesis
-
批准号:8677970
-
项目类别:
-
资助金额:$40.95万
-
财政年份:2012
-
负责人:Paul S Frenette
-
依托单位:
In vivo function of macrophage in healthy and diseased erythropoiesis
-
批准号:8550821
-
项目类别:
-
资助金额:$39.78万
-
财政年份:2012
-
负责人:Paul S Frenette
-
依托单位:
In vivo function of macrophage in healthy and diseased erythropoiesis
-
批准号:9172454
-
项目类别:
-
资助金额:$13.37万
-
财政年份:2012
-
负责人:Paul S Frenette
-
依托单位:
Role of mesenchymal stem cells in the blood stem cell niche
-
批准号:8309052
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2009
-
负责人:Paul S Frenette
-
依托单位:
Inhibition of platelet-leukocyte interactions to treat TRALI
-
批准号:7933939
-
项目类别:
-
资助金额:$45.15万
-
财政年份:2009
-
负责人:Paul S Frenette
-
依托单位:
Role of mesenchymal stem cells in the blood stem cell niche
-
批准号:7757961
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2009
-
负责人:Paul S Frenette
-
依托单位:
Mechanisms mediating circadian oscillations of leukocyte migration
-
批准号:7925749
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2009
-
负责人:Paul S Frenette
-
依托单位:
Mechanisms mediating circadian oscillations of leukocyte migration
-
批准号:8301648
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2009
-
负责人:Paul S Frenette
-
依托单位:
Inhibition of platelet-leukocyte interactions to treat TRALI
-
批准号:7814599
-
项目类别:
-
资助金额:$45.93万
-
财政年份:2009
-
负责人:Paul S Frenette
-
依托单位:
Mechanisms mediating circadian oscillations of leukocyte migration
-
批准号:7755169
-
项目类别:
-
资助金额:$42.28万
-
财政年份:2009
-
负责人:Paul S Frenette
-
依托单位:
Mechanisms mediating circadian oscillations of leukocyte migration
-
批准号:8120620
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2009
-
负责人:Paul S Frenette
-
依托单位:
Role of mesenchymal stem cells in the blood stem cell niche
-
批准号:8139175
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2009
-
负责人:Paul S Frenette
-
依托单位:
CLINICAL TRIAL: TREATMENT OF SICKLE CELL VASO-OCCLUSIVE CRISIS WITH HIGH DOSE IV
-
批准号:7718183
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2008
-
负责人:Paul S Frenette
-
依托单位:
TREATMENT OF SICKLE CELL VASO-OCCLUSIVE CRISIS WITH HIGH DOSE IVIG
-
批准号:7605368
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2007
-
负责人:Paul S Frenette
-
依托单位:
Assay development for high throughput screening of selectin ligand antagonists
-
批准号:7073254
-
项目类别:
-
资助金额:$16.95万
-
财政年份:2006
-
负责人:Paul S Frenette
-
依托单位:
Assay development for high throughput screening of selectin ligand antagonists
-
批准号:7285614
-
项目类别:
-
资助金额:$20.57万
-
财政年份:2006
-
负责人:Paul S Frenette
-
依托单位:
Assay development for high throughput screening of selectin ligand antagonists
-
批准号:7489373
-
项目类别:
-
资助金额:$20.18万
-
财政年份:2006
-
负责人:Paul S Frenette
-
依托单位:
HTS assay development for inhibitors of sickle cell
-
批准号:7060551
-
项目类别:
-
资助金额:$12.71万
-
财政年份:2005
-
负责人:Paul S Frenette
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: